TOCILIZUMAB AS MONOCLONAL ANTIBODY THERAPY IN OVERCOMING ACUTE RESPIRATORY DISTRESS SYNDROME IN COVID-19 PATIENTS. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, [S. l.], v. 9, n. 3, p. 92–101, 2022. DOI: 10.53366/jimki.v9i3.488. Disponível em: https://jimki.bapin.or.id/main/article/view/488. Acesso em: 28 jun. 2026.